Cutting edge:: NKG2D is a costimulatory receptor for human naive CD8+ T cells

被引:151
作者
Maasho, K [1 ]
Opoku-Anane, J [1 ]
Marusina, AI [1 ]
Coligan, JE [1 ]
Borrego, F [1 ]
机构
[1] NIAID, Receptor Cell Biol Sect, Lab Allerg Dis, NIH, Rockville, MD 20852 USA
关键词
D O I
10.4049/jimmunol.174.8.4480
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In humans, all alpha beta CD8(+) T cells express NKG2D, but in mouse, it is only expressed by activated and memory CD8(+) Tcells. We purified human naive CD8+ Tcells to show that NKG2D serves as a costimulatory receptor for TCR induced Ca2+ mobilization and proliferation. The resulting effector cells are skewed toward a type 1 phenotype and produce high levels of IFN-gamma and TNF-alpha NKG2D ligands, MHC class I chain-related (MIC)A, MICB, and UL16-binding proteins are expressed on the proliferating cells and NKG2D is down-regulated, The addition of the homeostatic cytokines IL-7 and IL-15 to the culture medium not only enhances proliferation but also counteracts the down-regulation of NKG2D, more so than the addition of IL-2. These results indicate that NKG2D can regulate the priming of human naive CD8+ Tcells, which may provide an alternative mechanism for potentiating and channeling the immune response.
引用
收藏
页码:4480 / 4484
页数:5
相关论文
共 50 条
  • [31] Costimulation through NKG2D enhances murine CD8+ CTL function:: Similarities and differences between NKG2D and CD28 costimulation
    Markiewicz, MA
    Carayannopoulos, LN
    Naidenko, OV
    Matsui, K
    Burack, WR
    Wise, EL
    Fremont, DH
    Allen, PM
    Yokoyama, WM
    Colonna, M
    Shaw, AS
    JOURNAL OF IMMUNOLOGY, 2005, 175 (05) : 2825 - 2833
  • [32] NKG2D Car T Cells are not affected by Soluble NKG2D Ligands
    Fernandez, Adrian
    Fernandez, Lucia
    Mirones, Isabel
    Escudero, Adela
    Cardoso, Leila
    Esteso, Gloria
    De Paz, Raquel
    Martinez-Lopez, Joaquin
    Vales, Mar
    Perez-Martinez, Antonio
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 243 - 243
  • [33] NKG2D receptor activation makes CD8+T cells resistant to the suppressive effects of TGF-β
    Prajapati, Kushal
    Perez, Cynthia
    Burke, Brianna
    Plaza-Rojas, Lourdes
    Guevara-Patino, Jose Alejandro
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [34] Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases
    Hu, Jiemiao
    Bernatchez, Chantale
    Zhang, Liangfang
    Xia, Xueqing
    Kleinerman, Eugenie S.
    Hung, Mien-Chie
    Hwu, Patrick
    Li, Shulin
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (04) : 300 - 311
  • [35] IL-21 down-regulates NKG2D expression and function in human NK cells and differentially regulates NKG2D and CD28 expression on CD8+T cells
    Burgess, Steven James
    Marusina, Alina
    Borrego, Francisco
    Coligan, John
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S27 - S27
  • [36] Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells (vol 103, pg 3065, 2004)
    Verneris, M. R.
    Karimi, Mobin
    Baker, J.
    Jayaswal, A.
    Negrin, R. S.
    BLOOD, 2015, 125 (16) : 2583 - 2583
  • [37] NKG2D signaling certifies effector CD8 T cells for memory formation
    Perez, Cynthia
    Prajapati, Kushal
    Burke, Brianna
    Plaza-Rojas, Lourdes
    Zeleznik-Le, Nancy J.
    Guevara-Patino, Jose A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [38] Silensilencing human NKG2D, DAP10 and DAP12 reduces cytotoxicity of in vivo activated CD8+ T and NK cells
    Karimi, MA
    Cao, T
    Verneris, MR
    Baker, J
    Negrin, RS
    BLOOD, 2004, 104 (11) : 130A - 131A
  • [39] Silencing human NKG2D, DAP10 and DAP12 reduces cytotoxicity of in vivo activated CD8+ T and NK cells
    Karami, MA
    Cao, TM
    Baker, J
    Verneris, MR
    Negrin, RS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 41 - 41
  • [40] TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors
    Maccalli, Cristina
    Scaramuzza, Samantha
    Parmiani, Giorgio
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (05) : 801 - 808